Documentation of the use of Varitect® CP in patients with herpes zoster, the VARIZOSTA study (NIS-022)

Study type

• Study type:
  Non-interventional study
• Scope of the study:
  Disease epidemiology

Population studied

• Age groups:
  • Adults (18 to < 46 years)
  • Adults (46 to < 65 years)
  • Adults (65 to < 75 years)
  • Adults (75 to < 85 years)
  • Adults (85 years and over)
• Estimated number of subjects:
  160

Study design details

• Main study objective:
  Assessment of the real-world usage of Varitect CP in patients with HZ. HZ patients, both treated with and without Varitect CP, will be documented in the NIS.
• Data analysis plan:
  All analyses will be exploratory. Since there are no confirmatory analyses planned, hypotheses are not formulated. Data will be analyzed using descriptive statistics. A statistical analysis plan will be prepared.